459
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Fragrances and work-related asthma–California surveillance data, 1993–2012

, MSEHS, CIH, , MPH & , MD, MPH
Pages 1041-1050 | Received 07 Jul 2016, Accepted 21 Feb 2017, Published online: 23 Mar 2017

References

  • Kumar P, Caradonna-Graham VM, Gupta S, Cai X, Rao P, Thompson J. Inhalation challenge effects of perfume scent strips in patients with asthma. Ann Allergy Asthma Immunol 1995;75;429–433.
  • Baur X, Schneider EM, Wieners D, Czuppon AB. Occupational asthma to perfume. Allergy 1999;54:1334–1335.
  • Quirce S, Fernández-Nieto M, del Pozo V, Sastre B, Sastre J. Occupational asthma and rhinitis caused by eugenol in a hairdresser. Allergy 2008;63:137.
  • López-Sáez MP, Carillo P, Huertas AJ, Fernández-Nieto M, López JD. Occupational asthma and dermatitis induced by eugenol in a cleaner. J Investig Allergol Clin Immunol 2015;25:64–65.
  • Caress SM, Steinemann AC. Prevalence of fragrance sensitivity in the American population. J Environ Health 2009;71:46–50.
  • Anderson RC, Anderson JH. Acute toxic effects of fragrance products. Arch Environ Health 1998;53:138–146.
  • Lessenger J. Occupational acute anaphylactic reaction to assault by perfume spray in the face. J Am Board Fam Pract 2001;14:137–140.
  • Shim C, Williams MH. Effect of odors on asthma. Am J Med 1986;80:18–22.
  • Brown EA, Colombo NJ. The asthmogenic effect of odors, smells, and fumes. Ann Allergy 1954;12:14–24.
  • Savonius B, Keskinen H, Tuppurainen M, Kanerva L. Occupational asthma caused by ethanolamines. Allergy 1994;49:877–881.
  • Elberling J, Skov PS, Mosbech H, Holst H, Dirksen A, Johansen JD. Increased release of histamine in patients with respiratory symptoms related to perfume. Clin Exp Allergy 2007;37:1676–1680.
  • Millqvist E, Löwhagen O. Placebo-controlled challenges with perfume in patients with asthma-like symptoms. Allergy 1996;51:434–439.
  • Låstbom L, Boman A, Johnsson S, Camner P, Ryrfeldt A. Increased airway responsiveness of a common fragrance component, 3-carene, after skin sensitisation—a study in isolated guinea pig lungs. Toxicol Lett 2003;145:189–196.
  • Dudek W, Wittczak T, Ś wierczyń ska-Machura D, Walusiak-Skorupa J, Pał czyń ski C. Occupational asthma due to turpentine in art painter—Case report. Int J Occup Med Environ Health 2009;22:293–295.
  • Ibrahim WH, Gheriani HA, Almohamed AA, Raza T. Paradoxical vocal cord motion disorder: past, present and future. Postgrad Med J 2007;83(977):164–172.
  • Hoy RF, Ribeiro M, Anderson J, Tarlo SM. Work-associated irritable larynx syndrome. Occup Med (Lond) 2010;60(7):546–551.
  • Traister RS, Fajt ML, Landsittel D, Petrov AA. A novel scoring system to distinguish vocal cord dysfunction from asthma. J Allergy Clin Immunol Pract 2014;2(1):65–69.
  • Anderson JA. Work-associated irritable larynx syndrome. Curr Opin Allergy Clin Immunol 2015;15(2):150–155.
  • Bickers DR, Calow P, Greim HA, Hanifin JM, Rogers AE, Saurat J-H, Sipes IG, Smith RL, Tagami H. The safety assessment of fragrance materials. Regul Toxicol Pharmacol 2003;37:218–273.
  • Bartsch J, Uhde E, Salthammer T. Analysis of odour compounds from scented comsumer products using gas chromatography-mass spectrometry and chromatography-olfactometry. Anal Chim Acta 2016;904:98–106.
  • Steinemann A, MacGregor I, Gordon S, Gallagher L, Davis A, Ribeiro D, Wallace L. Fragranced consumer products: Chemicals emitted, ingredients unlisted. Environ Imp Assess Rev 2011;31:328–333.
  • IFRA Survey: Transparency List [Internet]. Geneva: International Fragrance Association. [ cited 7 June 2016]. Available from: http://www.ifraorg.org/en-us/ingredients#.WA_n37mQypp
  • Rosenman KD, Beckett WS. Web based listing of agents associated with new onset work-related asthma. Respir Med 2015;109:625–631.
  • Uhde E, Schulz N. Impact of room fragrance products on indoor air quality. Atmos Environ 2015;106:492–502.
  • Nazaroff W, Weschler C. Cleaning products and air fresheners: exposure to primary and secondary air pollutants. Atmos Environ 2004;38:2841–2865.
  • Nørgaard AW, Kudal JD, Kofoed-Sørensen V, Koponen IK, Wolkoff P. Ozone-initiated VOC and particle emissions from a cleaning agent and air freshener: risk assessment of acute airway effects. Environ Int 2014;68:209–218.
  • Huang HL, Tsai TJ, Hsu NY, Lee CC, Wu PC, Su HJ. Effects of essential oils on the formation of formaldehyde and secondary organic aerosols in an aromatherapy environment. Build Environ 2012;57:120–125.
  • Nørgaard AW, Kofoed-Sørensen, Mandin C, Ventura G, Mabilia R, Perreca E, Cattaneo A, Spinazzè, Mihucz VG, Szigeti T, de Kluizenaar Y, Cornelissen HJM, Trantallidi M, Carrer P, Sakellaris I, Bartzis J, Wolkoff P. Ozone-initiated terpene reaction products in five European offices: replacement of a floor cleaning agent. Environ Sci Technol 2014;48:13331–13339.
  • Liu X, Mason M, Krebs K, Sparks L. Full-scale chamber investigation and simulation of air freshener emissions in the presence of ozone. Environ Sci Technol 2004;38:2802–2812.
  • Kim S, Hong SH, Bong CK, Cho MH. Characterization of air freshener emission: the potential health effects. J Toxicol Sci 2015;40:535–550.
  • Jajosky RA, Harrison R, Reinisch F, Flattery J, Chan J, Tumpowski C, Davis L, Reilly MJ, Rosenman KD, Kalinowski D, Stanbury M, Schill DP, Wood J. Surveillance of work-related asthma in selected U.S. states using surveillance guidelines for state health departments—California, Massachusetts, Michigan, and New Jersey, 1993–1995. MMWR Mor Mortal Wkly Rep 1999;48:1–20.
  • Reinisch F, Harrison RJ, Cussler S, Athanasoulis M, Balmes J, Blanc P, Cone J. Physician reports of work-related asthma in California, 1993–1996. Am J Ind Med 2001;39:72–83.
  • White GE, Seaman C, Filios MS, Mazurek JM, Flattery J, Harrison RJ, Reilly MJ, Rosenman KD, Lumia ME, Stephens AC, Pechter E, Fitzsimmons K, Davis LK. Gender differences in work-related asthma: surveillance data from California, Massachusetts, Michigan, and New Jersey, 1993–2008. J Asthma 2014;51:691–702.
  • Equal Employment Opportunity Tabulation [Internet]. Washington DC: US Department of Commerce, US Census Bureau. 2000. [ Cited 2016 Oct 17] Available from: http://www.census.gov/eeo2000/index.html
  • Moorman JE, Akinbami LJ, Bailey CM, Zahran HS, King ME, Johnson CA, Liu X. National surveillance of asthma: United States, 2001–2010. National Center for Health Statistics. Vital Health Stat 3(35):1–58.
  • Rhodes L, Moorman JE, Redd SC. Sex differences in asthma prevalence and other disease characteristics in eight states. J Asthma 2005;42:777–782.
  • Kynyk JA, Mastronarde JG, McCallister JW. Asthma, the sex difference. Curr Opin Pulm Med 2011;17:6–11.
  • McCallister JW, Mastronarde JG. Sex differences in asthma. J Asthma 2008;45:853–861.
  • The NPD Group, Inc. The NPD Group Reports on Men's Fragrance Usage. Port Washington, NY [ Internet]. 12 June 2013. [ cited .7 June 2016]. Available from: https://www.npd.com/wps/portal/npd/us/news/press-releases/the-npd-group-reports-on-mens-fragrance-usage/
  • Singer, N. The Sweet Smell of … Nothing. New York Times 2008 Feb 14. Sect. G:1.
  • Parsons JP, Benninger C, Hawley MP, Philips G, Forrest LA, Mastronarde JG. Vocal cord dysfunction: beyond severe asthma. Respir Med 2010;104(4):504–509.
  • Gimenez LM, Zafra H. Vocal cord dysfunction: an update. Ann Allergy Asthma Immunol 2011;106(4):267–274.
  • Traister RS, Fajt ML, Whitman-Purves E, Anderson WC, Petrov AA. A retrospective analysis comparing subjects with isolated and coexistent vocal cord dysfunction and asthma. Allergy Asthma Proc 2013;34(4):349–355.
  • Vandenplas O, Wiszniewska M, Raulf M, de Blay F, Gerth van Wijk R, Moscato G, Nemery B, Pala G, Quirce S, Sastre J, Schlünssen V, Sigsgaard T, Siracusa A, Tarlo SM, van Kampen V, Zock J-P, Walusiak-Skorupa J. EAACI position paper: irritant-induced asthma. Allergy 2014;69:1141–1153.
  • American Conference of Governmental Industrial Hygienists (ACGIH). Documentation of the Threshold Limit Values, Turpentine and selected monoterpenes 2014 Supplement to the 7th Edition. Cincinnati, OH 2014.
  • Tarlo S. Workplace Respiratory Irritants and Asthma. In: Wang ML, Banks DE, eds. Occupational medicine state of the art reviews—Occupational asthma. Philadelphia: Hanley & Belfus, 2000;15 (2):471–484.
  • Tarlo SM. Irritant-induced asthma in the workplace. Curr Allergy Asthma Rep 2014;14;1–6.
  • Burge PS, Moore VC, Robertson AS. Sensitization and irritant-induced occupational asthma with latency are clinically indistinguishable. Occup Med (Lond) 2012;62:129–133.
  • Brooks SM, Hammad Y, Richards I, Giovinco-Barbas J, Jenkins K. The spectrum of irritant-induced asthma. Chest 1998;113:42–49.
  • Tarlo SM, Broder I. Irritant-induced occupational asthma. Chest 1989;96:297–300.
  • Brooks SM, Weiss MA, Bernstein IL. Reactive Airways Dysfunction Syndrome (RADS)—persistent asthma syndrome after high level irritant exposures. Chest 1985;88:376–384.
  • Dumas O, Le Moual N. Do chronic workplace irritant exposures cause asthma? Curr Opin Allergy Clin Immunol 2016;16:75–85.
  • Occupational Safety and Health Administration—Hazard Communication Standard. 29 C.F.R Sect 1910.1200. (2012).
  • Fragrances in Cosmetics [Internet]. Silver Spring, MD: U.S. Food and Drug Administration. 2015 Dec 29 [ Cited: 2016 May 17]. Available from: http://www.fda.gov/Cosmetics/ProductsIngredients/Ingredients/ucm388821.htm
  • Hoppin P, Stillman L Jacobs M. Asthma: A business case for employers and health care purchasers. Lowell (MA): The Lowell Center for Sustainable Production, University of Massachusetts Lowell and Asthma Regional Council; 2010:28p.
  • Work-related Asthma Prevention Program Publications page [Internet]. Richmond (CA): California Department of Public Health, Occupational Health Branch; Fragrances and Work-Related Asthma: Information for Workers; Fragrances and Work-Related Asthma: Information for Employers; Workplace Fragrance-Free Policy. 2015 May [ Cited: 2016 Feb 19]. Available from: http://www.cdph.ca.gov/programs/ohsep/Pages/AsthmaPubs.aspx
  • Occupational Health & Safety--Scent Free Environment [Internet]. Newfoundland, Canada: Western Health; 2008 [ updated 2016 Jan 29; cited 2016 Oct 13]. Available from: http://westernhealth.nl.ca/uploads/PDFs/Western_Health_Scent_Free_Environment_Policy.pdf
  • Harrison Medical Center–Hospital Information [Internet]. Silverdale (WA): Catholic Health Initiatives Franciscan Health; 2016 [ Cited 2016 Oct 13]. Available from: https://www.chifranciscan.org/harrison-medical-center-silverdale/patients-and-visitors/hospital-information.html
  • S.C. Johnson & Son, Inc.—Brands you can trust [Internet]. Racine, WI; 2017 [ Cited 2017 Feb 7]. Available from: http://www.whatsinsidescjohnson.com/us/en/brands
  • Seventh Generation, Inc.—Products [Internet]. Burlington, VT; 2015 [Cited 2017 Feb 7]. Available from: https://www.seventhgeneration.com/products
  • Azaroff LS, Levenstein C, Webman DH. Occupational injury and illness surveillance: Conceptual filters explain underreporting. Am J Public Health 2002;92:1421–1429.
  • Flattery J, Davis L, Rosenman KD, Harrison R, Lyon-Callo S, Filios M. The proportion of self-reported asthma associated with work in three states: California, Massachusetts, and Michigan, 2001. J Asthma 2006;43:213–218.
  • Milet M, Lutzker L, Flattery J. Asthma in California: A surveillance report. Richmond (CA): California Department of Public Health; 2013:186 p.
  • California Labor Code, Division 5. Part 1. Occupational Safety and Health, Chapter 3, Section 6405.5(a) (2016).
  • Rutkow L, Vernick J, Teret S. Banning second-hand smoke in indoor public places under the Americans with Disabilities Act: a legal and public health imperative. Conn Law Rev 2007;40:1–46.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.